Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

N,N'-difluorophenyl derivative of 4-methoxyl-1,3-phthalamide and use thereof

A technology of difluorophenyl and phthalamide, which is applied in the field of anti-platelet aggregation and anti-inflammatory drugs, and can solve problems that have not yet been seen

Inactive Publication Date: 2010-06-30
TIANJIN UNIVERSITY OF TECHNOLOGY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the existing literature, there is no report of N, N'-difluoro-substituted phenyl derivatives and structural analogs thereof of 4-methoxy-1,3-phthalamide involved in the present invention and their use Anti-platelet aggregation, anti-inflammatory and antipyretic analgesic use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N,N'-difluorophenyl derivative of 4-methoxyl-1,3-phthalamide and use thereof
  • N,N'-difluorophenyl derivative of 4-methoxyl-1,3-phthalamide and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0473] Example 1: 4-methoxy-N, N'-bis-(3,5-difluorophenyl)-1,3-benzenedicarboxamide (C 21 h 14 f 4 N 2 o 3 )Synthesis

[0474] Dissolve 1.3g (10.1mmol) of 3,5-difluoroaniline in 15mL of tetrahydrofuran, add it to a 100mL round bottom flask, and dissolve 1.0g (4.3mmol) of 4-methoxy-1,3-phthaloyl chloride React in 10mL tetrahydrofuran for 6 hours. The solvent was evaporated. The solid was successively recrystallized from ethanol to obtain 1.2 g of white needle-like crystals. Yield: 66.7%, mp: 248-250°C.

[0475] The group number of the compound in the rabbit platelet aggregation reaction experiment is 9i.

[0476] Infrared spectroscopy (IR) and nuclear magnetic resonance spectroscopy ( 1 H-NMR) confirmed the structure of 9i: IR(KBr)cm -1 : 3362.5, 3102.9 (υ NH ), 1685.7, 1668.5 (υ C＝O ), 1607.9, 1559.7, 1495.9, 1431.1 (υ C＝C ), 1311.3(υ C-N ), 1266.6, 1020.2 (υ C-O-C ), 1101.7(υ CF ), 843.6, 828.1, 669.5 (υ CH ); 1 H-NMR (Acetone) δ (ppm): 4.18 (s, 3H, -OCH 3 ...

Embodiment 2

[0477] Example 2: 4-methoxy-N, N'-bis(3,5-difluorophenyl)-1,3-benzenedisulfonamide (C 19 h 14 f 4 N 2 o 5 S 2 )Synthesis

[0478] Dissolve 1.0g (7.8mmol) of 3,5-difluoroaniline in 10mL of tetrahydrofuran, add it to a 100mL round bottom flask, add 1.0g (3.3mmol) of 4-methoxy-1,3-benzenedisulfonyl chloride React in the above-mentioned reaction bottle for 6 hours. The solvent was evaporated. The solid was recrystallized from ethanol to obtain 1.0 g of white crystals. Yield: 61.7%, mp: 212-214°C.

[0479] The group number of the compound in the rabbit platelet aggregation reaction experiment is 10j.

[0480] Infrared spectroscopy (IR) and nuclear magnetic resonance spectroscopy ( 1 H-NMR) confirmed the structure of 10j: IR (KBr) cm -1 : 3256.6, 3114.4 (υ NH ), 2953.0 (υ CH3 ), 1626.1, 1488.4, 1438.5, 1410.1 (υ C＝C ), 1285.8, 1064.1 (υ C-O-C ), 1350.9, 1185.3, 1163.3 (υ SO2 ), 1309.4(υ C-N ), 993.3(υ CF ), 892.8, 838.8, 708.7 (υ CH ); 1 H-NMR (Acetone) δ (ppm): ...

Embodiment 3

[0481] Example 3: 4-methoxy-N, N'-bis(3-trifluoromethyl-4-fluorophenyl)-1,3-benzenedicarboxamide (C 23 h 14 f 8 N 2 o 3 )Synthesis

[0482] Dissolve 1.0g (5.6mmol) of 3-trifluoromethyl-4-fluoroaniline in 10mL of tetrahydrofuran into a 100mL round-bottomed flask, and add 0.6g (2.6mmol) of 4-methoxy-1,3-benzenedimethoxy The acid chloride was dissolved in 10 mL of tetrahydrofuran and added to the above reaction flask to react for 6 hours. The solvent was evaporated. The solid was recrystallized from ethanol to obtain 1.0 g of taupe solid. Yield: 75.2%, mp: 224-226°C.

[0483] The group number of the compound in the rabbit platelet aggregation reaction experiment is 11k.

[0484] Infrared spectroscopy (IR) and nuclear magnetic resonance spectroscopy ( 1 H-NMR) confirmed the 11k structure: IR (KBr) cm -1 : 3357.0(υ NH), 1675.4, 1654.7 (υ C＝o ), 1552.0, 1505.3, 1427.2 (υ C＝C ), 1329.4(υ CF3 ), 1270.1(υ C-N ), 1250.0(υ C-N ), 1054.2(υ C-O-C ), 1125.0(υ CF ); 1 H-NM...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an N, N'-difluoro-substituted-phenyl derivative of 4-methoxyl-1, 3-phenyldiamide, and relative applications. The compound has activity of suppressing platelet aggregation, and can be used for treating the diseases such as cardiac infarction, cerebrovascular disorder, pulmonary embolism and atherosclerosis, with antipyretic, analgesia and antiphlogistic activities.

Description

【Technical field】 [0001] The invention belongs to the field of anti-platelet aggregation and anti-inflammatory drugs, in particular a kind of N, N'-difluoro-substituted phenyl derivatives of 4-methoxy-1,3-phthalamide with anti-platelet aggregation activity Or pharmaceutically acceptable salts, compositions and uses thereof. 【Background technique】 [0002] Platelet aggregation is the main factor causing various (heart, brain, lung, etc.) thrombi. Therefore, the research on antithrombotic drugs has been focusing on the field of anti-platelet aggregation. Platelet aggregation is a key link in the normal coagulation mechanism, and the adhesion, aggregation and release reactions of platelets lead to thrombus formation. Anti-platelet aggregation drugs refer to drugs that can inhibit the adhesion and aggregation of platelets and inhibit the formation of thrombus, so they play an important role in the treatment of thrombosis. Oral antiplatelet drugs are currently the most commonl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C235/64C07C231/02C07C303/38C07C311/29
Inventor 刘秀杰王松青
Owner TIANJIN UNIVERSITY OF TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com